|
Current issue
Archive
Videos
Articles in press
About the journal
Supplements
Editorial board
Reviewers
Abstracting and indexing
Subscription
Contact
Instructions for authors
Publication charge
Ethical standards and procedures
Editorial System
Submit your Manuscript
|
4/2013
vol. 115 abstract:
Original paper
Vitreous hemorrhages in proliferative diabetic retinopathy treated with pars plana vitrectomy – own material
Piotr Kanclerz
1
,
Joanna Pyrzanowska-Sumiła
1
,
Joanna Murawska
1
,
Dorota Raczyńska
1
,
Andrzej Gębka
1
Klinika Oczna 2013, 115 (4): 291-295
Online publish date: 2013/12/22
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Introduction
The paper presents the retrospective analysis of diabetic patients with vitreous hemorrhage due to proliferative retinopathy treated surgically with vitrectomy at the Department of Ophthalmology, Medical University of Gdansk in 2008–2010. The aim of the study was to evaluate the effect of tamponade and antiplatelet/anticoagulation treatment on the recurrence of vitreous hemorrhage. Material and methods The pars plana vitrectomy was performed in 68 diabetic patients (76 eyes) with vitreous hemorrhage secondary to proliferative retinopathy. Multiple pars plana vitrectomy was performed in 4 patients, both eyes were operated in 8 patients. The patients’ age ranged from 27 to 87 years. The correlation between the duration of insulin therapy, degree of disease progression, antiplatelet/anticoagulation treatment, the time since the last vitrectomy, type of vitreous tamponade, and the recurrence of hemorrhages were evaluated. The follow-up was 12 months. Results Overall, 83 pars plana vitrectomy procedures were performed. Silicone oil was used in 42 procedures, and expandable gas in 9 cases. 32 eyes were left without any tamponade. During the follow-up the vitreous hemorrhage reoccurred in 10 cases – including 5 eyes left without the tamponade, 4 eyes with gas tamponade and 1 eye with silicone oil tamponade. Conclusions Pars plana vitrectomy with sillicon oil tamponade ensures the effective hemostasis in patients with proliferative diabetic retinopathy. The antiplatelet/anticoagulation treatment does not influence the incidence or the recurrence of vitreous hemorrhage. keywords:
proliferative diabetic retinopathy, vitreous hemorrhage, pars plana vitrectomy |
|
POLSKI
